NEW YORK (GenomeWeb) – Belgium-based Biocartis said late Wednesday that it raised €55.5 million ($63.1 million) in gross proceeds through a private placement via an accelerated bookbuild offering of 5 million new shares. The firm said earlier the same day it sought to raise €45 million in the equity placement, then increased it to €55 million.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.